What are the treatment options for molluscum contagiosum?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment Options for Molluscum Contagiosum

Molluscum contagiosum typically resolves spontaneously within 6-12 months without treatment, but several treatment options are available for cases that are cosmetically bothersome, symptomatic, or to reduce transmission risk.

Natural Course and When to Treat

  • Molluscum contagiosum is a common, benign viral skin infection presenting as skin-colored papules with central umbilication 1
  • Affects 5-11% of children aged 0-16 years, most commonly on the trunk, face, and extremities 1
  • Spontaneous resolution typically occurs within 6-12 months, though complete resolution can take up to 4 years 1
  • Treatment is indicated primarily for:
    • Cosmetically bothersome lesions
    • Patients with underlying skin conditions like eczema
    • Symptomatic cases (pain, itching, redness)
    • Reducing risk of transmission
    • Athletes participating in contact sports

First-Line Treatment Options

Physical Removal Methods

  1. Incision and Curettage:

    • Involves aggressive curettage to cause bleeding 1
    • Effective for immediate removal of visible lesions
    • May be painful and potentially frightening for young children
  2. Cryotherapy with Liquid Nitrogen:

    • Similar efficacy to other treatments in children 1
    • Caution: May cause postinflammatory hyperpigmentation or scarring 1
    • High-quality evidence from a randomized controlled trial showed cantharidin was more effective than placebo (36.2% vs 10.6% clearance rate) 2
  3. Simple Excision:

    • Direct removal of lesions 1
    • Best for isolated, larger lesions
  4. Excision and Cautery:

    • Combines removal with heat treatment 1
    • More definitive but potentially more painful

Topical Treatments

  1. 10% Potassium Hydroxide (KOH):

    • Effective treatment option 1
    • Comparative studies show it may be more effective than 5% imiquimod (faster onset of action) 3
    • Higher incidence of side effects than imiquimod 3
  2. Cantharidin:

    • Open-label and observational studies indicate effectiveness 1
    • Recent high-quality evidence from a randomized controlled trial showed 36.2% clearance rate compared to 10.6% with placebo 2
    • Well-tolerated with minimal side effects 2

Second-Line and Less Effective Options

  1. Imiquimod 5% cream:

    • Multiple high-quality studies show lack of effectiveness compared to vehicle/placebo 4
    • Moderate-quality evidence shows no difference in clinical cure rates at 12,18, or 28 weeks 4
    • May cause application site reactions (erythema, itching, burning) 5, 4
    • FDA labeling indicates it was not effective in pediatric trials 5
  2. Other Topical Agents:

    • 10% Australian lemon myrtle oil (limited evidence) 4
    • 10% benzoyl peroxide cream 4
    • 5% sodium nitrite with 5% salicylic acid 4
    • Iodine plus tea tree oil 4

Treatment Algorithm

  1. For asymptomatic, limited lesions in immunocompetent patients:

    • Consider observation for spontaneous resolution
    • Monitor for 3-6 months
  2. For bothersome, extensive, or symptomatic lesions:

    • First choice: Cantharidin application or 10% potassium hydroxide
    • Alternative: Cryotherapy with liquid nitrogen (caution regarding pigmentation changes)
  3. For lesions in sensitive areas or in young/anxious children:

    • 10% potassium hydroxide solution applied 3 times weekly
    • Consider cantharidin for its well-tolerated profile
  4. For athletes participating in contact sports:

    • More aggressive treatment approach to prevent transmission
    • Cover lesions during competition until fully resolved
    • Follow specific return-to-play guidelines from athletic organizations 1

Special Considerations

  • Immunocompromised patients: May require more aggressive treatment and monitoring
  • Ocular involvement: Lesions on eyelids require prompt treatment to prevent conjunctivitis 1
  • Children: Consider less painful options; avoid imiquimod as studies show lack of efficacy 5, 4
  • Multiple lesions: Identify and treat nascent lesions to reduce recurrence risk 1

Common Pitfalls and Caveats

  1. Overtreatment: Remember that spontaneous resolution is common; aggressive treatment may not be necessary for all cases
  2. Imiquimod use: Despite widespread use, high-quality evidence shows it's no more effective than placebo 4
  3. Pain management: Physical removal methods can be painful; consider topical anesthetics for children
  4. Secondary infection: Monitor for signs of bacterial superinfection
  5. Recurrence: New lesions may appear during treatment course; patient education is important

In adults with large and multiple molluscum lesions with minimal inflammation, consider evaluation for immunocompromised state 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.